(Q44594442)

English

Five weeks of insulin-like growth factor-I treatment does not alter glucose kinetics or insulin sensitivity during a hyperglycemic clamp in older women

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Five weeks of insulin-like growth factor-I treatment does not alter glucose kinetics or insulin sensitivity during a hyperglycemic clamp in older women (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

glucose clamp technique

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506625

13 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506625

13 March 2024

1 reference

10.1016/S0026-0495(03)00166-5

https://api.crossref.org/works/10.1016/S0026-0495(03)00166-5

13 March 2024

author name string

Barry Braun

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Margaret Pollack

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Robert Marcus

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Anne L. Friedlander

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506625

13 March 2024

Gail E. Butterfield

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506625

13 March 2024

Andrew R. Hoffman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506625

13 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14506625

13 March 2024

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:S0026049503001665?httpAccept=text/plain

1 reference

10.1016/S0026-0495(03)00166-5

https://api.crossref.org/works/10.1016/S0026-0495(03)00166-5

13 March 2024

https://api.elsevier.com/content/article/PII:S0026049503001665?httpAccept=text/xml

1 reference

10.1016/S0026-0495(03)00166-5

https://api.crossref.org/works/10.1016/S0026-0495(03)00166-5

13 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1182-1190

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Age-Related Changes in Serum Insulin-Like Growth Factor-Binding Proteins in Women*

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Insulin resistance with aging: effects of diet and exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Insulin sensitivity in postmenopausal women: independent and combined associations with hormone replacement, cardiovascular fitness, and body composition.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Insulin-like growth factors (IGFs) and IGF-binding proteins in the developing rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Fuel selection in human skeletal muscle in insulin resistance: a reexamination

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Cellular mechanisms of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Postmenopausal hormone replacement therapy and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Clinical uses of insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900166-5

7 January 2021

Effect of physical training on the insulin resistance of aging

15

1 reference

10.1016/S0026-0495(03)00166-5

https://api.crossref.org/works/10.1016/S0026-0495(03)00166-5

13 March 2024

One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women

25

1 reference

10.1016/S0026-0495(03)00166-5

https://api.crossref.org/works/10.1016/S0026-0495(03)00166-5

13 March 2024

glucose clamp technique

26

1 reference

10.1016/S0026-0495(03)00166-5

https://api.crossref.org/works/10.1016/S0026-0495(03)00166-5

13 March 2024

Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake

33

1 reference

10.1016/S0026-0495(03)00166-5

https://api.crossref.org/works/10.1016/S0026-0495(03)00166-5

13 March 2024

Identifiers

10.1016/S0026-0495(03)00166-5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

release_vg4avcdoubcmxb3gli73anpphe

1 reference

https://api.fatcat.wiki/v0/release/vg4avcdoubcmxb3gli73anpphe

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44594442&oldid=2101293802"